These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17276009)

  • 1. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
    Dutta T; Jain NK
    Biochim Biophys Acta; 2007 Apr; 1770(4):681-6. PubMed ID: 17276009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers.
    Gajbhiye V; Ganesh N; Barve J; Jain NK
    Eur J Pharm Sci; 2013 Mar; 48(4-5):668-79. PubMed ID: 23298577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.
    Dutta T; Agashe HB; Garg M; Balakrishnan P; Kabra M; Jain NK
    J Drug Target; 2007 Jan; 15(1):89-98. PubMed ID: 17365278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.
    Dutta T; Garg M; Jain NK
    Eur J Pharm Sci; 2008 Jul; 34(2-3):181-9. PubMed ID: 18501568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral and cellular metabolism interactions between Dexelvucitabine and lamivudine.
    Hernandez-Santiago BI; Mathew JS; Rapp KL; Grier JP; Schinazi RF
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2130-5. PubMed ID: 17403996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral effect of lamivudine on HIV-1 targeting MT2 cells influenced by morphine].
    Liang BY; Zhuang DM; Jiang JJ; Liu SY; Su QJ; Li JY; Liang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jul; 32(7):705-8. PubMed ID: 21933545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
    Rossi L; Franchetti P; Pierigé F; Cappellacci L; Serafini S; Balestra E; Perno CF; Grifantini M; Caliò R; Magnani M
    J Antimicrob Chemother; 2007 Apr; 59(4):666-75. PubMed ID: 17327293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interactions between apricitabine and other deoxycytidine analogues.
    Bethell R; De Muys J; Lippens J; Richard A; Hamelin B; Ren C; Collins P
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2948-53. PubMed ID: 17517847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors.
    Balzarini J; De Clercq E; Carbonez A; Burt V; Kleim JP
    AIDS Res Hum Retroviruses; 2000 Apr; 16(6):517-28. PubMed ID: 10777142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages.
    Aquaro S; Svicher V; Ceccherini-Silberstein F; Cenci A; Marcuccilli F; Giannella S; Marcon L; Caliò R; Balzarini J; Perno CF
    J Antimicrob Chemother; 2005 Jun; 55(6):872-8. PubMed ID: 15845785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sho-saiko-to, a traditional Kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro.
    Piras G; Makino M; Baba M
    Microbiol Immunol; 1997; 41(10):835-9. PubMed ID: 9403512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
    Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes.
    Garg M; Garg BR; Jain S; Mishra P; Sharma RK; Mishra AK; Dutta T; Jain NK
    Eur J Pharm Sci; 2008 Mar; 33(3):271-81. PubMed ID: 18249529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.
    Borroto-Esoda K; Vela JE; Myrick F; Ray AS; Miller MD
    Antivir Ther; 2006; 11(3):377-84. PubMed ID: 16759055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
    Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
    Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a metabolic and antiviral drug interaction between tenofovir, abacavir and lamivudine.
    Ray AS; Myrick F; Vela JE; Olson LY; Eisenberg EJ; Borroto-Esodo K; Miller MD; Fridland A
    Antivir Ther; 2005; 10(3):451-7. PubMed ID: 15918336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hydroxyurea on the phosphorylation of zidovudine and lamivudine in human umbilical vein endothelial cells.
    McGuire TR; Hoie EB; Manouilov KK; Gwilt PG
    In Vitro Cell Dev Biol Anim; 2003; 39(7):280-2. PubMed ID: 14572303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.
    Saavedra-Lozano J; McCoig CC; Cao Y; Vitetta ES; Ramilo O
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2825-30. PubMed ID: 15273087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
    Trabaud MA; Leriche-Guerin K; Regis C; Bordes I; Cotte L; Detmer J; Kolberg J; Ritter J; Trépo C
    J Med Virol; 2000 Jul; 61(3):352-9. PubMed ID: 10861645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.